Minimal residual disease in multiple myeloma: use of magnetic resonance imaging
The increasing percentage of patients achieving deep responses in multiple myeloma has led to the need for more sophisticated instruments to measure residual disease as a potential source of relapse. As minimal residual disease assessment is mostly performed on a bone marrow specimen from a certain...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 February 2018
|
| In: |
Seminars in hematology
Year: 2018, Jahrgang: 55, Heft: 1, Pages: 19-21 |
| ISSN: | 1532-8686 |
| DOI: | 10.1053/j.seminhematol.2018.02.001 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1053/j.seminhematol.2018.02.001 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0037196318300015 
|
| Verfasserangaben: | Jens Hillengass, Maximilian Merz, Stefan Delorme |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 168741338X | ||
| 003 | DE-627 | ||
| 005 | 20230427090145.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200115s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.seminhematol.2018.02.001 |2 doi | |
| 035 | |a (DE-627)168741338X | ||
| 035 | |a (DE-599)KXP168741338X | ||
| 035 | |a (OCoLC)1341298084 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 245 | 1 | 0 | |a Minimal residual disease in multiple myeloma |b use of magnetic resonance imaging |c Jens Hillengass, Maximilian Merz, Stefan Delorme |
| 264 | 1 | |c 12 February 2018 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 12 February 2018 | ||
| 500 | |a Gesehen am 15.01.2020 | ||
| 520 | |a The increasing percentage of patients achieving deep responses in multiple myeloma has led to the need for more sophisticated instruments to measure residual disease as a potential source of relapse. As minimal residual disease assessment is mostly performed on a bone marrow specimen from a certain area of the body, such samples have the limitation that they might not really represent the actual tumor burden, because focal accumulations of malignant cells might be either hit or missed. Magnetic resonance imaging is a highly sensitive technique for the assessment of tumor burden and can be performed as whole-body protocol, overcoming the problem of sampling error for minimal residual disease assessment. Despite its high sensitivity, however, magnetic resonance imaging cannot differentiate between vital and necrotic lesions after therapy. Therefore, new fusion and functional techniques are currently under investigation, and image-guided biopsies are performed to combine the strengths of all available methods. | ||
| 650 | 4 | |a Magnetic resonance imaging | |
| 650 | 4 | |a Minimal Residual Disease | |
| 650 | 4 | |a Multiple Myeloma | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Response Assessment | |
| 650 | 4 | |a Treatment Monitoring | |
| 700 | 1 | |a Merz, Maximilian |d 1985- |e VerfasserIn |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 aut | |
| 700 | 1 | |a Delorme, Stefan |e VerfasserIn |0 (DE-588)105842808X |0 (DE-627)796879761 |0 (DE-576)179470140 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in hematology |d Philadelphia, Pa. : Saunders, 2000 |g 55(2018), 1, Seite 19-21 |h Online-Ressource |w (DE-627)346436486 |w (DE-600)2078098-9 |w (DE-576)099026112 |x 1532-8686 |7 nnas |a Minimal residual disease in multiple myeloma use of magnetic resonance imaging |
| 773 | 1 | 8 | |g volume:55 |g year:2018 |g number:1 |g pages:19-21 |g extent:3 |a Minimal residual disease in multiple myeloma use of magnetic resonance imaging |
| 856 | 4 | 0 | |u https://doi.org/10.1053/j.seminhematol.2018.02.001 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0037196318300015 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200115 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 105842808X |a Delorme, Stefan |m 105842808X:Delorme, Stefan |p 3 |y j | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 910000 |d 910100 |e 910000PM1023626950 |e 910100PM1023626950 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN168741338X |e 3575504806 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Minimal residual disease in multiple myeloma","subtitle":"use of magnetic resonance imaging","title_sort":"Minimal residual disease in multiple myeloma"}],"person":[{"role":"aut","given":"Jens","display":"Hillengaß, Jens","family":"Hillengaß"},{"role":"aut","given":"Maximilian","display":"Merz, Maximilian","family":"Merz"},{"family":"Delorme","role":"aut","given":"Stefan","display":"Delorme, Stefan"}],"name":{"displayForm":["Jens Hillengass, Maximilian Merz, Stefan Delorme"]},"note":["Available online 12 February 2018","Gesehen am 15.01.2020"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["346436486"],"issn":["1532-8686"],"zdb":["2078098-9"]},"disp":"Minimal residual disease in multiple myeloma use of magnetic resonance imagingSeminars in hematology","note":["Gesehen am 10.02.25"],"origin":[{"dateIssuedDisp":"2000-","publisher":"Saunders","dateIssuedKey":"2000","publisherPlace":"Philadelphia, Pa."}],"recId":"346436486","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Seminars in hematology","title":"Seminars in hematology"}],"language":["eng"],"part":{"pages":"19-21","extent":"3","issue":"1","volume":"55","year":"2018","text":"55(2018), 1, Seite 19-21"},"pubHistory":["Nachgewiesen 37.2000 -"]}],"id":{"eki":["168741338X"],"doi":["10.1053/j.seminhematol.2018.02.001"]},"physDesc":[{"extent":"3 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"12 February 2018","dateIssuedKey":"2018"}],"recId":"168741338X"} | ||
| SRT | |a HILLENGASSMINIMALRES1220 | ||